companydata.dkcompanydata.dk

Azebiotics ApS: Financial statements 2025

CVR: 40503021

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Azebiotics ApS (CVR 40503021) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 67,779 and a net result of DKK 57,784 compared with DKK 176,367 the year before. That is a decrease of 63.8% compared with the year before. Equity in the 2025 report amounted to DKK -288,030.

Gross Profit
DKK 67,779
Profit/Loss
DKK 57,784
Equity
DKK -288,030
Total Assets
DKK 5,170
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-68 t.58 t.-288 t.0
2024-187 t.176 t.-346 t.-
2023--104 t.-94 t.-522 t.-
2022--103 t.-92 t.-428 t.-
2021--143 t.-123 t.-336 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Azebiotics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Azebiotics ApS: The 2024 annual report is outJun 29, 2025

Azebiotics ApS has published its annual report for 2024. Gross profit came to DKK 187,175, and the net result was DKK 176,367.

About Azebiotics ApS

Azebiotics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mikkel Bender. The company's owners include ECHOSTAR HOLDING ApS, MEVA HOLDING ApS and Frederik Ammitzbøll Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 67,779 and a net result of DKK 57,784 compared with DKK 176,367 the year before. Equity in the 2025 report amounted to DKK -288,030.

Source: annual report 2025, Danish Business Authority

Other financial years